0 XP   0   0   0

Harpoon Therapeutics Inc










Financial Health of Harpoon Therapeutics Inc




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Harpoon Therapeutics Inc
Buy, Hold or Sell?

Should you buy, hold or sell Harpoon Therapeutics Inc?

I guess you are interested in Harpoon Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Harpoon Therapeutics Inc

Let's start. I'm going to help you getting a better view of Harpoon Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Harpoon Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Harpoon Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Harpoon Therapeutics Inc. The closing price on 2022-12-07 was $0.7076 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Harpoon Therapeutics Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of Harpoon Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Harpoon Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -209.0% means that $-2.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harpoon Therapeutics Inc:

  • The MRQ is -209.0%. The company is making a huge loss. -2
  • The TTM is -141.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-209.0%TTM-141.4%-67.5%
TTM-141.4%YOY-366.5%+225.0%
TTM-141.4%5Y-534.1%+392.7%
5Y-534.1%10Y-507.4%-26.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-209.0%-223.6%+14.6%
TTM-141.4%-281.7%+140.3%
YOY-366.5%-344.8%-21.7%
5Y-534.1%-450.1%-84.0%
10Y-507.4%-541.0%+33.6%
1.1.2. Return on Assets

Shows how efficient Harpoon Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • -15.9% Return on Assets means that Harpoon Therapeutics Inc generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harpoon Therapeutics Inc:

  • The MRQ is -15.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-13.7%-2.3%
TTM-13.7%YOY-11.5%-2.2%
TTM-13.7%5Y-12.1%-1.6%
5Y-12.1%10Y-11.5%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%-9.9%-6.0%
TTM-13.7%-8.9%-4.8%
YOY-11.5%-9.3%-2.2%
5Y-12.1%-11.7%-0.4%
10Y-11.5%-12.7%+1.2%
1.1.3. Return on Equity

Shows how efficient Harpoon Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • -65.1% Return on Equity means Harpoon Therapeutics Inc generated $-0.65 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harpoon Therapeutics Inc:

  • The MRQ is -65.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -43.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-65.1%TTM-43.3%-21.9%
TTM-43.3%YOY-30.4%-12.8%
TTM-43.3%5Y-26.9%-16.4%
5Y-26.9%10Y-25.5%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-65.1%-12.0%-53.1%
TTM-43.3%-11.5%-31.8%
YOY-30.4%-10.8%-19.6%
5Y-26.9%-14.2%-12.7%
10Y-25.5%-15.2%-10.3%

1.2. Operating Efficiency of Harpoon Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Harpoon Therapeutics Inc is operating .

  • Measures how much profit Harpoon Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -207.7% means the company generated $-2.08  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harpoon Therapeutics Inc:

  • The MRQ is -207.7%. The company is operating very inefficient. -2
  • The TTM is -140.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-207.7%TTM-140.9%-66.8%
TTM-140.9%YOY-366.5%+225.5%
TTM-140.9%5Y-534.0%+393.1%
5Y-534.0%10Y-507.3%-26.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-207.7%-207.3%-0.4%
TTM-140.9%-271.0%+130.1%
YOY-366.5%-325.9%-40.6%
5Y-534.0%-454.0%-80.0%
10Y-507.3%-537.1%+29.8%
1.2.2. Operating Ratio

Measures how efficient Harpoon Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.10 means that the operating costs are $3.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 3.097. The company is inefficient in keeping operating costs low. -1
  • The TTM is -0.097.
Trends
Current periodCompared to+/- 
MRQ3.097TTM-0.097+3.194
TTM-0.097YOY3.302-3.399
TTM-0.0975Y8.562-8.659
5Y8.56210Y8.134+0.428
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0972.871+0.226
TTM-0.0973.504-3.601
YOY3.3023.604-0.302
5Y8.5625.132+3.430
10Y8.1346.371+1.763

1.3. Liquidity of Harpoon Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Harpoon Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.62 means the company has $1.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 1.615. The company is able to pay all its short-term debts. +1
  • The TTM is 2.190. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.615TTM2.190-0.575
TTM2.190YOY2.949-0.759
TTM2.1905Y4.286-2.096
5Y4.28610Y4.072+0.214
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6155.117-3.502
TTM2.1905.755-3.565
YOY2.9495.854-2.905
5Y4.2866.511-2.225
10Y4.0726.222-2.150
1.3.2. Quick Ratio

Measures if Harpoon Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.92 means the company can pay off $1.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 1.919. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.353. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.919TTM3.353-1.434
TTM3.353YOY4.988-1.635
TTM3.3535Y6.109-2.756
5Y6.10910Y5.803+0.305
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9194.284-2.365
TTM3.3534.664-1.311
YOY4.9884.787+0.201
5Y6.1095.218+0.891
10Y5.8035.182+0.621

1.4. Solvency of Harpoon Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Harpoon Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Harpoon Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.76 means that Harpoon Therapeutics Inc assets are financed with 75.5% credit (debt) and the remaining percentage (100% - 75.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 0.755. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.657. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.755TTM0.657+0.098
TTM0.657YOY0.625+0.032
TTM0.6575Y0.884-0.227
5Y0.88410Y0.863+0.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7550.278+0.477
TTM0.6570.277+0.380
YOY0.6250.306+0.319
5Y0.8840.367+0.517
10Y0.8630.403+0.460
1.4.2. Debt to Equity Ratio

Measures if Harpoon Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 308.9% means that company has $3.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 3.089. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.059. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.089TTM2.059+1.030
TTM2.059YOY1.729+0.330
TTM2.0595Y1.721+0.338
5Y1.72110Y1.679+0.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0890.315+2.774
TTM2.0590.317+1.742
YOY1.7290.319+1.410
5Y1.7210.403+1.318
10Y1.6790.462+1.217

2. Market Valuation of Harpoon Therapeutics Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Harpoon Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -3.64 means the investor is paying $-3.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harpoon Therapeutics Inc:

  • The EOD is -1.350. Company is losing money. -2
  • The MRQ is -3.644. Company is losing money. -2
  • The TTM is -9.754. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.350MRQ-3.644+2.294
MRQ-3.644TTM-9.754+6.110
TTM-9.754YOY-32.325+22.571
TTM-9.7545Y-19.180+9.426
5Y-19.18010Y-18.221-0.959
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.350-8.986+7.636
MRQ-3.644-9.792+6.148
TTM-9.754-16.243+6.489
YOY-32.325-20.876-11.449
5Y-19.180-16.665-2.515
10Y-18.221-14.732-3.489
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Harpoon Therapeutics Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is -21.291. Very Bad. -2
  • The TTM is -823.297. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-21.291TTM-823.297+802.006
TTM-823.297YOY159.036-982.333
TTM-823.2975Y49.590-872.887
5Y49.59010Y49.5900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.291-0.032-21.259
TTM-823.2970.004-823.301
YOY159.0360.016+159.020
5Y49.5900.006+49.584
10Y49.5900.003+49.587

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Harpoon Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.37 means the investor is paying $2.37 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Harpoon Therapeutics Inc:

  • The EOD is 0.879. Very good. +2
  • The MRQ is 2.373. Good. +1
  • The TTM is 3.513. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD0.879MRQ2.373-1.494
MRQ2.373TTM3.513-1.139
TTM3.513YOY7.822-4.309
TTM3.5135Y3.835-0.322
5Y3.83510Y3.643+0.192
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8791.835-0.956
MRQ2.3732.006+0.367
TTM3.5132.774+0.739
YOY7.8223.453+4.369
5Y3.8352.713+1.122
10Y3.6432.402+1.241
2. Total Gains per Share

2.4. Latest News of Harpoon Therapeutics Inc

Does Harpoon Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Harpoon Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-11-19
13:12
Analysts Just Published A Bright New Outlook For Harpoon Therapeutics, Inc.'s (NASDAQ:HARP)Read
2022-11-14
23:25
Harpoon Therapeutics, Inc. (HARP) Reports Q3 Loss, Tops Revenue EstimatesRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Harpoon Therapeutics Inc.

3.1. Institutions holding Harpoon Therapeutics Inc

Institutions are holding 73.035% of the shares of Harpoon Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30MPM Oncology Impact Management LP9.65581.6961319670700
2022-06-30New Leaf Venture Partners, L.L.C.9.53493.9057315669900
2022-06-30Mpm Asset Management, LLC9.45852.5238313138800
2022-06-30Orbimed Advisors, LLC9.18090.1052303950800
2022-06-30Franklin Resources Inc4.00070.00131324504-338649-20.3619
2022-06-30Vanguard Group Inc3.6420.00011205751-82451-6.4005
2022-06-30Artal Group S A3.02050.102100000000
2022-06-30Point72 Asset Management, L.P.2.630.007870700-297615-25.4739
2022-06-30Candriam Luxembourg S.C.A.2.39430.012579268900
2022-06-30Millennium Management LLC1.75170.00075799195620533145.9364
2022-06-30Cormorant Asset Management, LLC1.63290.078154060000
2022-06-30Jacobs Levy Equity Management, Inc.0.99630.0049329842-42255-11.3559
2022-06-30Renaissance Technologies Corp0.95860.000731736110616150.2656
2022-06-30Tekla Capital Management LLC0.78510.019525991000
2022-06-30Schonfeld Strategic Advisors LLC0.72560.0044240221215589.859
2022-06-30Geode Capital Management, LLC0.69090.0001228734-168457-42.4121
2022-06-30Goldman Sachs Group Inc0.6310.00012089204735329.3086
2022-06-30Federated Hermes Inc0.40110.00071327914121245.0016
2022-06-30Citadel Advisors Llc0.39080.00011293961293960
2022-06-30Kennedy Capital Management Inc0.33610.006111284-1070-0.9523
Total 62.81778.46920796924-22764-0.1%

3.2. Funds holding Harpoon Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Worldwide Healthcare Ord4.4290.1029146630000
2022-09-30Franklin Biotechnology Discv A(acc)USD2.65180.044687791600
2022-09-30Candriam Global Equities Oncology2.23070.041773851600
2022-09-30Belfius Equities Cure C Cap2.23070.041973851600
2022-10-31Vanguard Total Stock Mkt Idx Inv2.08740.000169106300
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr2.08740.0001691063-53121-7.1382
2022-09-30Franklin Biotechnology Discovery A1.3450.053744529900
2022-10-31Vanguard Extended Market Index Investor0.93160.000330841700
2022-09-30Kennedy Micro Cap0.87560.0715289875178591160.4822
2022-06-30Tekla Life Sciences Investors0.78510.126625991000
2022-07-31Biotech Growth Ord0.60890.085320160000
2022-03-31BlackRock Advantage Small Cap Core Instl0.53860.02071783207695175.9118
2022-10-31iShares Biotechnology ETF0.42780.00161416416780.481
2022-09-30Fidelity® Extended Market Index0.37830.000412525000
2022-10-31Vanguard VIF Small Co Gr0.29680.00659826000
2022-06-30BlackRock Extended Mkt Composite0.16510.000954646546460
2022-06-30Bridgeway Ultra-Small Company Market0.1510.050250000-41861-45.5699
2022-09-30BlackRock Extended Equity Market K0.14570.000548249-444-0.9118
2022-08-31Fidelity® Small Cap Enhanced Index0.12950.01244286700
2022-10-31iShares Micro-Cap ETF0.1090.00363610200
Total 22.6050.66557483810+215440+2.9%

3.3. Insider Transactions

Insiders are holding 7.684% of the shares of Harpoon Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-09-22Georgia ErbezBUY103008.1
2021-07-01Holger WescheSELL100001462852
2021-06-01Ansbert GadickeSELL1849120.44
2021-05-28Ansbert GadickeSELL1388521.12
2021-05-26Ansbert GadickeSELL319820.04
2021-05-24Ansbert GadickeSELL500020.12
2021-05-21Ansbert GadickeSELL1090720.21
2021-05-19Ansbert GadickeSELL1783320.39
2021-05-17Ansbert GadickeSELL466620.07
2021-05-14Ansbert GadickeSELL690020.04
2021-05-12Ansbert GadickeSELL2968420.53
2021-05-10Ansbert GadickeSELL1713321.8
2021-05-04Impact Fund (cayman) OncologySELL32851922.48
2021-04-29Impact Fund (cayman) OncologySELL13014321.99
2021-04-21Ansbert GadickeSELL897218.97
2021-04-19Ansbert GadickeSELL1005619.3
2021-04-16Ansbert GadickeSELL584719.86
2021-04-14Bioventures 2014 L.p. MpmSELL167120.77
2021-04-12Ansbert GadickeSELL2062821.02
2021-04-09Ansbert GadickeSELL1030023.67

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Harpoon Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.445-0.485+9%0.144-410%0.035-1364%0.040-1207%
Book Value Growth---0.553-0.366-34%0.009-6219%-0.127-77%-0.127-77%
Book Value Per Share--0.8051.533-48%2.325-65%1.503-46%1.435-44%
Book Value Per Share Growth---0.553-0.366-34%0.009-6219%-0.127-77%-0.127-77%
Current Ratio--1.6152.190-26%2.949-45%4.286-62%4.072-60%
Debt To Asset Ratio--0.7550.657+15%0.625+21%0.884-15%0.863-13%
Debt To Equity Ratio--3.0892.059+50%1.729+79%1.721+80%1.679+84%
Dividend Per Share----0%-0%-0%-0%
Eps---0.524-0.573+9%-0.779+49%-0.464-11%-0.441-16%
Eps Growth--0.1710.003+6299%0.498-66%0.132+29%0.132+29%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.950+5%
Net Profit Margin---2.090-1.414-32%-3.665+75%-5.341+156%-5.074+143%
Operating Margin---2.077-1.409-32%-3.665+76%-5.340+157%-5.073+144%
Operating Ratio--3.097-0.097+103%3.302-6%8.562-64%8.134-62%
Pb Ratio0.879-170%2.3733.513-32%7.822-70%3.835-38%3.643-35%
Pe Ratio-1.350+63%-3.644-9.754+168%-32.325+787%-19.180+426%-18.221+400%
Peg Ratio---21.291-823.297+3767%159.036-113%49.590-143%49.590-143%
Price Per Share0.708-170%1.9105.583-66%17.098-89%8.938-79%8.491-78%
Price To Total Gains Ratio-1.589+63%-4.289-11.528+169%-38.969+808%-27.833+549%-27.833+549%
Profit Growth--17.1170.267+6307%49.785-66%1.364+1155%1.364+1155%
Quick Ratio--1.9193.353-43%4.988-62%6.109-69%5.803-67%
Return On Assets---0.159-0.137-14%-0.115-28%-0.121-24%-0.115-28%
Return On Equity---0.651-0.433-34%-0.304-53%-0.269-59%-0.255-61%
Revenue Growth--0.2890.064+354%0.099+191%0.130+122%0.130+122%
Total Gains Per Share---0.445-0.485+9%0.144-410%0.035-1364%0.040-1207%
Total Gains Per Share Growth--0.132-0.044+133%-0.865+756%-1.277+1068%-1.277+1068%
Usd Book Value--26642000.00050766500.000-48%76972250.000-65%49756947.368-46%47493200.000-44%
Usd Book Value Change Per Share---0.445-0.485+9%0.144-410%0.035-1364%0.040-1207%
Usd Book Value Per Share--0.8051.533-48%2.325-65%1.503-46%1.435-44%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.524-0.573+9%-0.779+49%-0.464-11%-0.441-16%
Usd Price Per Share0.708-170%1.9105.583-66%17.098-89%8.938-79%8.491-78%
Usd Profit---17351000.000-18976250.000+9%-25788000.000+49%-15377789.474-11%-14608900.000-16%
Usd Revenue--8303000.0003174000.000+162%6557500.000+27%2959000.000+181%2811050.000+195%
Usd Total Gains Per Share---0.445-0.485+9%0.144-410%0.035-1364%0.040-1207%
 EOD+3 -2MRQTTM+15 -17YOY+13 -195Y+13 -1910Y+14 -19

4.2. Fundamental Score

Let's check the fundamental score of Harpoon Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.350
Price to Book Ratio (EOD)Between0-10.879
Net Profit Margin (MRQ)Greater than0-2.090
Operating Margin (MRQ)Greater than0-2.077
Quick Ratio (MRQ)Greater than11.919
Current Ratio (MRQ)Greater than11.615
Debt to Asset Ratio (MRQ)Less than10.755
Debt to Equity Ratio (MRQ)Less than13.089
Return on Equity (MRQ)Greater than0.15-0.651
Return on Assets (MRQ)Greater than0.05-0.159
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Harpoon Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.700
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets108,951
Total Liabilities82,309
Total Stockholder Equity26,642
 As reported
Total Liabilities 82,309
Total Stockholder Equity+ 26,642
Total Assets = 108,951

Assets

Total Assets108,951
Total Current Assets94,037
Long-term Assets94,037
Total Current Assets
Cash And Cash Equivalents 68,568
Short-term Investments 21,585
Other Current Assets 3,884
Total Current Assets  (as reported)94,037
Total Current Assets  (calculated)94,037
+/-0
Long-term Assets
Property Plant Equipment 14,045
Other Assets 869
Long-term Assets  (as reported)14,914
Long-term Assets  (calculated)14,914
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities58,223
Long-term Liabilities24,086
Total Stockholder Equity26,642
Total Current Liabilities
Short-term Debt 1,767
Accounts payable 2,790
Other Current Liabilities 17,162
Total Current Liabilities  (as reported)58,223
Total Current Liabilities  (calculated)21,719
+/- 36,504
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt9,632
Other Liabilities 14,454
Long-term Liabilities  (as reported)24,086
Long-term Liabilities  (calculated)24,086
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -322,464
Accumulated Other Comprehensive Income -56
Other Stockholders Equity 349,158
Total Stockholder Equity (as reported)26,642
Total Stockholder Equity (calculated)26,642
+/-0
Other
Capital Stock4
Cash and Short Term Investments 90,153
Common Stock Shares Outstanding 33,037
Current Deferred Revenue36,504
Liabilities and Stockholders Equity 108,951
Net Debt -57,169
Net Invested Capital 26,642
Net Tangible Assets 26,642
Net Working Capital 35,814
Short Long Term Debt Total 11,399



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
> Total Assets 
8,384
31,872
0
0
32,307
102,580
166,932
157,016
142,388
176,604
162,496
197,122
183,321
171,592
261,317
196,177
174,669
155,452
132,447
108,951
108,951132,447155,452174,669196,177261,317171,592183,321197,122162,496176,604142,388157,016166,932102,58032,3070031,8728,384
   > Total Current Assets 
0
29,647
0
0
28,933
90,223
140,653
137,322
122,991
150,617
128,697
174,784
157,724
129,754
234,281
175,678
156,192
137,695
116,945
94,037
94,037116,945137,695156,192175,678234,281129,754157,724174,784128,697150,617122,991137,322140,65390,22328,9330029,6470
       Cash And Cash Equivalents 
985
29,423
0
0
27,858
89,493
95,926
52,094
56,764
88,736
36,168
34,738
22,651
21,170
71,335
77,413
42,993
44,687
50,738
68,568
68,56850,73844,68742,99377,41371,33521,17022,65134,73836,16888,73656,76452,09495,92689,49327,8580029,423985
       Short-term Investments 
0
0
0
0
0
0
42,646
81,790
64,463
59,337
86,929
136,882
132,156
104,860
158,078
93,604
108,395
90,411
61,727
21,585
21,58561,72790,411108,39593,604158,078104,860132,156136,88286,92959,33764,46381,79042,646000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
1,100
1,800
0
0
0
0
0
0
860
0
0
008600000001,8001,100000000000
   > Long-term Assets 
0
2,225
0
0
3,374
12,357
26,279
19,694
19,397
25,987
33,799
22,338
25,597
41,838
27,036
20,499
18,477
17,757
15,502
14,914
14,91415,50217,75718,47720,49927,03641,83825,59722,33833,79925,98719,39719,69426,27912,3573,374002,2250
       Property Plant Equipment 
90
2,087
0
0
2,264
2,998
13,618
19,227
18,876
18,398
17,893
17,641
17,195
16,771
16,242
15,558
14,936
15,375
14,689
14,045
14,04514,68915,37514,93615,55816,24216,77117,19517,64117,89318,39818,87619,22713,6182,9982,264002,08790
       Long Term Investments 
0
0
0
0
0
0
8,978
0
0
7,056
15,143
3,829
7,514
23,946
9,989
4,194
2,841
1,522
0
0
001,5222,8414,1949,98923,9467,5143,82915,1437,056008,978000000
       Other Assets 
0
138
0
0
1,110
9,359
605
467
521
533
763
868
888
1,121
805
747
700
860
813
869
8698138607007478051,1218888687635335214676059,3591,110001380
> Total Liabilities 
3,902
58,815
0
0
76,290
156,059
33,338
34,543
35,157
82,384
79,202
125,216
122,579
117,753
158,937
105,249
97,699
97,382
91,063
82,309
82,30991,06397,38297,699105,249158,937117,753122,579125,21679,20282,38435,15734,54333,338156,05976,2900058,8153,902
   > Total Current Liabilities 
3,862
6,916
0
0
7,580
11,948
11,897
14,507
16,686
22,513
23,814
39,046
45,214
47,918
98,163
54,694
55,381
59,139
58,583
58,223
58,22358,58359,13955,38154,69498,16347,91845,21439,04623,81422,51316,68614,50711,89711,9487,580006,9163,862
       Short-term Debt 
0
0
0
0
0
0
572
0
0
0
0
0
1,363
1,202
1,202
1,536
1,592
1,649
1,707
1,767
1,7671,7071,6491,5921,5361,2021,2021,36300000572000000
       Short Long Term Debt 
0
0
0
0
0
0
572
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000572000000
       Accounts payable 
281
1,174
0
0
1,746
4,357
3,411
4,519
3,900
2,594
1,545
1,586
1,779
1,572
2,641
1,997
1,598
2,666
4,189
2,790
2,7904,1892,6661,5981,9972,6411,5721,7791,5861,5452,5943,9004,5193,4114,3571,746001,174281
       Other Current Liabilities 
1,269
1,492
0
0
1,584
3,341
4,236
5,738
8,706
8,712
8,395
10,368
11,798
13,845
64,681
16,342
14,045
17,362
15,812
17,162
17,16215,81217,36214,04516,34264,68113,84511,79810,3688,3958,7128,7065,7384,2363,3411,584001,4921,269
   > Long-term Liabilities 
0
51,899
0
0
68,710
144,111
21,441
20,036
18,471
59,871
55,388
86,170
77,365
69,835
60,774
50,555
42,318
38,243
32,480
24,086
24,08632,48038,24342,31850,55560,77469,83577,36586,17055,38859,87118,47120,03621,441144,11168,7100051,8990
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
14,712
15,231
15,038
14,944
14,658
14,369
12,690
12,313
12,082
11,399
10,973
10,538
10,094
9,632
9,63210,09410,53810,97311,39912,08212,31312,69014,36914,65814,94415,03815,23114,712000000
       Warrants
0
0
0
0
0
129,577
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000129,57700000
       Long-term Liabilities Other 
0
0
0
0
0
14,534
14,712
0
18,471
59,871
55,388
86,170
77,365
69,835
60,774
50,555
42,318
0
0
0
00042,31850,55560,77469,83577,36586,17055,38859,87118,471014,71214,53400000
       Deferred Long Term Liability 
0
0
0
0
0
3,000
0
0
0
0
0
0
0
600
0
0
0
200
0
0
0020000060000000003,00000000
> Total Stockholder Equity
4,482
-26,943
-26,943
0
-43,983
-53,479
133,594
122,473
107,231
94,220
83,294
71,906
60,742
53,839
102,380
90,928
76,970
58,070
41,384
26,642
26,64241,38458,07076,97090,928102,38053,83960,74271,90683,29494,220107,231122,473133,594-53,479-43,9830-26,943-26,9434,482
   Common Stock
1
1
0
0
1
1
3
3
3
3
3
3
3
3
4
4
4
4
4
4
44444433333333110011
   Retained Earnings Total Equity00-284,792-263,241-246,558-229,795-168,071-156,714-143,407-130,715-118,163-103,8950-76,170-62,59100000
   Accumulated Other Comprehensive Income 
0
-370
0
0
-804
-1,014
-1,311
-1,611
-1,414
-1,914
-2,417
-2,929
-3,459
3
-17
-2
0
-47
-88
-56
-56-88-470-2-173-3,459-2,929-2,417-1,914-1,414-1,611-1,311-1,014-80400-3700
   Capital Surplus 
0
0
0
0
0
9,111
209,735
210,347
211,038
212,339
213,535
215,068
217,326
221,904
332,188
337,484
340,207
342,905
0
0
00342,905340,207337,484332,188221,904217,326215,068213,535212,339211,038210,347209,7359,11100000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
8,651
0
0
9,680
10,125
211,072
212,068
212,537
214,294
216,423
218,239
220,912
221,904
332,188
337,484
340,207
342,905
346,581
349,158
349,158346,581342,905340,207337,484332,188221,904220,912218,239216,423214,294212,537212,068211,07210,1259,680008,6510



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue23,654
Cost of Revenue--
Gross Profit23,65423,654
 
Operating Income (+$)
Gross Profit23,654
Operating Expense-140,405
Operating Income-116,751-116,751
 
Operating Expense (+$)
Research Development72,124
Selling General Administrative18,327
Selling And Marketing Expenses-
Operating Expense140,40590,451
 
Net Interest Income (+$)
Interest Income240
Interest Expense-0
Net Interest Income240240
 
Pretax Income (+$)
Operating Income-116,751
Net Interest Income240
Other Non-Operating Income Expenses-20
Income Before Tax (EBT)-116,721-116,781
EBIT - interestExpense = -116,721
-116,721
-116,721
Interest Expense0
Earnings Before Interest and Taxes (ebit)-116,721-116,721
Earnings Before Interest and Taxes (ebitda)-114,531
 
After tax Income (+$)
Income Before Tax-116,721
Tax Provision--
Net Income From Continuing Ops-116,771-116,721
Net Income-116,721
Net Income Applicable To Common Shares-116,721
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring49,954
Other Operating Expenses-
Total Other Income/Expenses Net30-220
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
MWC.CC
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of MWC.CC.

MWC.CC Daily Candlestick Chart
MTC.CC
1 minute ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of MTC.CC.

MTC.CC Daily Candlestick Chart
MOB.CC
3 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MOB.CC.

MOB.CC Daily Candlestick Chart
MAID.CC
12 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MAID.CC.

MAID.CC Daily Candlestick Chart
LIKE.CC
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LIKE.CC.

LIKE.CC Daily Candlestick Chart
LBK.CC
18 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of LBK.CC.

LBK.CC Daily Candlestick Chart
JOINT.CC
23 minutes ago

I found you a Death Cross on the daily chart of JOINT.CC.

JOINT.CC Daily Candlestick Chart
ION.CC
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ION.CC.

ION.CC Daily Candlestick Chart
RV.V
32 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RV.V.

RV.V Daily Candlestick Chart
SCL.TO
34 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of SCL.TO.

SCL.TO Daily Candlestick Chart
PRU.TO
39 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PRU.TO.

PRU.TO Daily Candlestick Chart
XSQ.TO
45 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XSQ.TO.

XSQ.TO Daily Candlestick Chart
NA.TO
47 minutes ago

I found you a Golden Cross on the daily chart of NA.TO.

NA.TO Daily Candlestick Chart
MNT.TO
48 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MNT.TO.

MNT.TO Daily Candlestick Chart
MOGO.TO
48 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MOGO.TO.

MOGO.TO Daily Candlestick Chart
L.TO
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of L.TO.

L.TO Daily Candlestick Chart
HZD.TO
56 minutes ago

I found you a Death Cross on the daily chart of HZD.TO.

HZD.TO Daily Candlestick Chart
TLGN.PINK
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of TLGN.PINK.

TLGN.PINK Daily Candlestick Chart
GXE.TO
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GXE.TO.

GXE.TO Daily Candlestick Chart
NHK.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NHK.TO.

NHK.TO Daily Candlestick Chart
ZMU.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZMU.TO.

ZMU.TO Daily Candlestick Chart
PNPN.V
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PNPN.V.

PNPN.V Daily Candlestick Chart
TRL.TO
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of TRL.TO.

TRL.TO Daily Candlestick Chart
VBNK.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VBNK.TO.

VBNK.TO Daily Candlestick Chart
VCB.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VCB.TO.

VCB.TO Daily Candlestick Chart